Bing obtained her PhD degree in December 2019 from Imperial College London. The main focus of her research was epigenetic gene regulation in vivo. She joined BGI Genomics as a senior PM after graduation. In August 2021, she started her academic career as a post-doctoral at Tumor Research Institute of Qingdao University. The main research interest is to identify new cardio-protectant for chemotherapeutic drug cardiotoxicity. Postdoctoral supervisor: Professor Dong-ming Xing.